• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

放射治疗在局限性食管癌和胃癌中的作用

The Role of Radiotherapy in Localized Esophageal and Gastric Cancer.

作者信息

Ng John, Lee Percy

机构信息

Department of Radiation Oncology, Weill Cornell Medical College, New York-Presbyterian Hospital, 525 East 68th Street, N-046, New York, NY 10065, USA.

Department of Radiation Oncology, Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California Los Angeles, 200 UCLA Medical Plaza, B265, Los Angeles, CA 90095, USA.

出版信息

Hematol Oncol Clin North Am. 2017 Jun;31(3):453-468. doi: 10.1016/j.hoc.2017.01.005. Epub 2017 Mar 22.

DOI:10.1016/j.hoc.2017.01.005
PMID:28501087
Abstract

Multimodality management has become a core treatment principle for locally advanced esophageal, gastroesophageal junction (GEJ), and gastric cancer. Radiotherapy serves an important role for optimizing patient outcomes. This article reviews the evolving role of radiotherapy in the multidisciplinary management of esophageal, GEJ, and gastric cancer, summarizing the results of recent clinical trials leading to contemporary accepted treatment approaches. A major theme is the evidence supporting the role of radiotherapy in combined modality management, particularly the trend toward its delivery in the neoadjuvant setting. Also reviewed are novel radiotherapy paradigms and newer radiation technologies such as image-guided radiotherapy and MRI-guided radiotherapy.

摘要

多模态管理已成为局部晚期食管癌、胃食管交界部(GEJ)癌和胃癌的核心治疗原则。放射治疗在优化患者治疗效果方面发挥着重要作用。本文回顾了放射治疗在食管癌、GEJ癌和胃癌多学科管理中不断演变的作用,总结了近期临床试验的结果,这些结果促成了当代公认的治疗方法。一个主要主题是支持放射治疗在联合治疗模式中作用的证据,特别是在新辅助治疗环境中进行放射治疗的趋势。还回顾了新型放射治疗模式和更新的放射技术,如图像引导放射治疗和磁共振成像引导放射治疗。

相似文献

1
The Role of Radiotherapy in Localized Esophageal and Gastric Cancer.放射治疗在局限性食管癌和胃癌中的作用
Hematol Oncol Clin North Am. 2017 Jun;31(3):453-468. doi: 10.1016/j.hoc.2017.01.005. Epub 2017 Mar 22.
2
Comparative effectiveness in esophagogastric cancer.食管癌和胃癌的比较疗效
Cancer Treat Res. 2015;164:121-42. doi: 10.1007/978-3-319-12553-4_8.
3
Advances in the Management of Gastric and Gastroesophageal Cancers.胃癌和胃食管癌管理的进展
Curr Oncol Rep. 2016 Feb;18(2):13. doi: 10.1007/s11912-015-0493-6.
4
Controversies in the treatment of local and locally advanced gastric and esophageal cancers.局部和局部进展期胃和食管癌症治疗的争议。
J Clin Oncol. 2015 Jun 1;33(16):1754-9. doi: 10.1200/JCO.2014.59.7765. Epub 2015 Apr 27.
5
[Radiotherapy in cancers of the oesophagus, the gastric cardia and the stomach].[食管癌、贲门癌和胃癌的放射治疗]
Cancer Radiother. 2016 Sep;20 Suppl:S161-8. doi: 10.1016/j.canrad.2016.07.039. Epub 2016 Aug 11.
6
Preoperative and adjuvant therapies for upper gastrointestinal cancers.上消化道癌的术前治疗和辅助治疗。
Expert Rev Anticancer Ther. 2005 Aug;5(4):719-25. doi: 10.1586/14737140.5.4.719.
7
Clinical management of gastroesophageal junction tumors: past and recent evidences for the role of radiotherapy in the multidisciplinary approach.胃食管交界部肿瘤的临床管理:放疗在多学科治疗中作用的既往及近期证据
Radiat Oncol. 2014 Feb 5;9:45. doi: 10.1186/1748-717X-9-45.
8
Gastroesophageal Junction Adenocarcinoma: Is There an Optimal Management?胃食管交界腺癌:是否存在最佳治疗方案?
Am Soc Clin Oncol Educ Book. 2019 Jan;39:e88-e95. doi: 10.1200/EDBK_236827. Epub 2019 May 17.
9
Cancer of the gastroesophageal junction: combined modality therapy.胃食管交界部癌:综合治疗
Surg Oncol Clin N Am. 2006 Oct;15(4):803-24. doi: 10.1016/j.soc.2006.07.011.
10
Technical considerations in radiation therapy for gastroesophageal junction cancer.胃食管结合部癌放射治疗的技术考虑因素。
Semin Radiat Oncol. 2013 Jan;23(1):51-9. doi: 10.1016/j.semradonc.2012.09.005.

引用本文的文献

1
Risk analysis of cardiovascular mortality after gastric cancer diagnosis: a large population-based study.胃癌诊断后心血管疾病死亡率的风险分析:一项基于大规模人群的研究。
Front Cardiovasc Med. 2025 Apr 22;12:1459151. doi: 10.3389/fcvm.2025.1459151. eCollection 2025.
2
Clinical-radiomics nomogram for the risk prediction of esophageal fistula in patients with esophageal squamous cell carcinoma treated with intensity-modulated radiation therapy or volumetric-modulated arc therapy.用于预测接受调强放射治疗或容积调强弧形治疗的食管鳞状细胞癌患者食管瘘风险的临床-放射组学列线图。
J Thorac Dis. 2024 Mar 29;16(3):2032-2048. doi: 10.21037/jtd-24-191. Epub 2024 Mar 20.
3
Targeted ferritinophagy in gastrointestinal cancer: from molecular mechanisms to implications.
靶向胃肠道癌铁蛋白自噬:从分子机制到意义。
Arch Toxicol. 2024 Jul;98(7):2007-2018. doi: 10.1007/s00204-024-03745-y. Epub 2024 Apr 11.
4
CircATIC inhibits esophageal carcinoma progression and promotes radiosensitivity by elevating RHCG through sponging miR-10-3p.CircATIC 通过海绵吸附 miR-10-3p 升高 RHCG 抑制食管癌细胞进展并增强放射敏感性。
Thorac Cancer. 2022 Apr;13(7):934-946. doi: 10.1111/1759-7714.14326. Epub 2022 Mar 20.
5
Long-term clinical outcomes of lipiodol marking using standard gastroscopy for image-guided radiotherapy of upper gastrointestinal cancers.使用标准胃镜对胃上部癌症进行图像引导放射治疗时,碘油标记的长期临床结果。
World J Gastroenterol. 2021 Nov 14;27(42):7387-7401. doi: 10.3748/wjg.v27.i42.7387.
6
miR-20b and miR-125a promote tumorigenesis in radioresistant esophageal carcinoma cells.miR-20b 和 miR-125a 促进放射抵抗性食管癌细胞的肿瘤发生。
Aging (Albany NY). 2021 Mar 10;13(7):9566-9581. doi: 10.18632/aging.202690.
7
Effects of radioactive I on apoptosis of HGC-27 gastric cancer cells.放射性碘对人胃癌细胞系HGC-27凋亡的影响。
Oncol Lett. 2019 Nov;18(5):4916-4922. doi: 10.3892/ol.2019.10832. Epub 2019 Sep 9.
8
Integrating radiosensitive genes improves prediction of radiosensitivity or radioresistance in patients with oesophageal cancer.整合放射敏感基因可改善食管癌患者放射敏感性或放射抗性的预测。
Oncol Lett. 2019 Jun;17(6):5377-5388. doi: 10.3892/ol.2019.10240. Epub 2019 Apr 10.
9
Hypoxia-Induced Upregulation of HE4 Is Responsible for Resistance to Radiation Therapy of Gastric Cancer.缺氧诱导的HE4上调是胃癌放疗抵抗的原因。
Mol Ther Oncolytics. 2018 Dec 6;12:49-55. doi: 10.1016/j.omto.2018.11.004. eCollection 2019 Mar 29.
10
TM4SF1 inhibits apoptosis and promotes proliferation, migration and invasion in human gastric cancer cells.TM4SF1抑制人胃癌细胞的凋亡,并促进其增殖、迁移和侵袭。
Oncol Lett. 2018 Nov;16(5):6081-6088. doi: 10.3892/ol.2018.9411. Epub 2018 Sep 6.